Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 individuals...

Full description

Bibliographic Details
Published in:The Lancet Global Health
Main Author: Murphy A.; Palafox B.; O'Donnell O.; Stuckler D.; Perel P.; AlHabib K.F.; Avezum A.; Bai X.; Chifamba J.; Chow C.K.; Corsi D.J.; Dagenais G.R.; Dans A.L.; Diaz R.; Erbakan A.N.; Ismail N.; Iqbal R.; Kelishadi R.; Khatib R.; Lanas F.; Lear S.A.; Li W.; Liu J.; Lopez-Jaramillo P.; Mohan V.; Monsef N.; Mony P.K.; Puoane T.; Rangarajan S.; Rosengren A.; Schutte A.E.; Sintaha M.; Teo K.K.; Wielgosz A.; Yeates K.; Yin L.; Yusoff K.; Zatońska K.; Yusuf S.; McKee M.
Format: Article
Language:English
Published: Elsevier Ltd 2018
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044636388&doi=10.1016%2fS2214-109X%2818%2930031-7&partnerID=40&md5=8cb7bd9c36760fe13fa43d671fe8120d

Similar Items